Neurokinin Receptor Antagonists Trend 2026

Neurokinin receptor antagonists block substance P, a neuropeptide involved in pain and inflammation. By binding to NK1 receptors in the brain and gut, these drugs prevent vomiting and nausea signals. They benefit chemotherapy patients, those with motion sickness, and individuals with chronic pain conditions like fibromyalgia, offering targeted relief without widespread side effects.